Why Do Recurring UTIs Keep Coming Back? The Biology Nobody Explains

A Semaine Health education guide. Reviewed against the published research; sources linked throughout.

The short answer

If you keep getting urinary tract infections, it usually isn't bad luck or poor hygiene. Recurrence is built into the biology: the bacteria that cause UTIs — most often E. coli from the gut — don't just float in urine waiting to be flushed out. They grip the bladder wall, slip inside its surface cells, and form protected, biofilm-like reservoirs that survive long after symptoms fade. Clear the bacteria you can feel, and the reservoir can reseed weeks later. That's why "another UTI" is so often the same population returning. Understanding that contest — grip versus flush — is the difference between managing episodes and addressing the root.

Here's what's actually happening.

How common is this, really?

More common than anyone tells you. According to a 2019 review in Therapeutic Advances in Urology, the lifetime incidence of UTI in adult women is 50–60%, and prevalence roughly doubles in women over 65 (Medina & Castillo-Pino, 2019). A Duke review puts it similarly: up to 40% of women experience at least one UTI in their lifetime (Wu, Miao & Abraham, 2017). And recurrence is the rule, not the exception — among women who get one UTI, a substantial share get another (Fu et al., 2017).

So if it feels like this keeps happening to you, the data agrees. The interesting question is why.

What a UTI actually is — at the root

A urinary tract infection begins when bacteria reach the urinary tract and attach to the bladder lining. The attaching is the key event. Free-floating bacteria get flushed out when you urinate; bacteria that have gripped the bladder wall do not. So your body's first defense is mechanical — flow — and the bacteria's first move is to defeat flow by holding on (Foxman, 2010).

Why recurrence is so common: reservoirs on (and in) the bladder wall

Once uropathogenic E. coli attach, they don't stay tidy individuals on the surface. Research shows they can invade the superficial cells lining the bladder and form protected communities — biofilm-like reservoirs — that the normal flush can't reach (Wu, Miao & Abraham, 2017). The bladder isn't passive in this fight; its epithelial cells can actually expel invading bacteria. But the reservoir is the problem: it shelters bacteria, persists after symptoms stop, and can release them again when conditions shift — which reads as a brand-new infection but is often the same population that never fully left.

Your recurring urinary concerns are telling you something: the issue isn't only the bacteria you can feel — it's the foothold they've established to survive.

Why menopause changes the picture

If urinary issues became a recurring part of your life around perimenopause or after — when they may never have been before — that timing isn't a coincidence. Estrogen helps maintain the urinary and vaginal environment: the tissue and the microbial balance that keep pathogenic bacteria like E. coli in check. As estrogen declines, that environment shifts and becomes more hospitable to bacteria, and the urinary microbiome itself changes with menopausal status (Bhide, Tailor & Khullar, 2020). It's why urinary concerns climb with age (Eriksson et al., 2009). Post-menopausal urinary shifts have a hormonal cause — the biology is explainable; it's just rarely explained.

Why antibiotics don't end the cycle

Antibiotics clear an active infection, and they matter. But they don't dismantle the reservoir, and repeated courses select for resistant bacteria while disrupting the gut and vaginal microbiota that help protect you (Foxman, 2010). Rising resistance is exactly why clinical guidelines now emphasize reducing unnecessary antibiotics and exploring non-antibiotic prevention (Anger et al., AUA/CUA/SUFU Guideline, 2019; Sihra et al., 2018). The goal isn't to replace treatment — it's to support the urinary environment so the cycle has less to feed on.

What the research shows cranberry can — and can't — do

Almost everyone reaches for cranberry, and the current landmark review settles much of the old debate: a 2023 Cochrane systematic review of 50 studies (8,857 participants) found cranberry products reduced symptomatic, culture-verified UTIs by 30% overall (RR 0.70, 95% CI 0.58–0.84) and by 26% in women with recurrent UTIs (RR 0.74, 95% CI 0.55–0.99) (Williams et al., 2023, Cochrane Database Syst Rev). The honest reading: the benefit is real for recurrence-prone women but the form matters enormously (more on that in our evidence guide), and even good cranberry is supportive, not a cure. Two things have actually been measured for the compounds in standardized cranberry:

• Against E. coli: reduced adhesion. Cranberry proanthocyanidins (PACs) reduce uropathogenic E. coli's ability to grip bladder cells, in a dose-dependent way, when the active compounds reach the urine (Howell et al., 2010; de Llano et al., 2015).
• Against biofilm formation: inhibition in laboratory models. The cranberry compounds that show up in human urine after dosing inhibit biofilm formation by a biofilm-forming organism (Candida albicans) in lab and ex-vivo testing (Baron et al., 2019; Ottaviano et al., 2021).

One caveat worth stating plainly: the benefit is not universal. The same Cochrane review found little to no benefit in elderly institutionalised people, in pregnancy, and in neurogenic-bladder patients, and at least one large trial found no benefit in older nursing-home women (Juthani-Mehta et al., 2016, JAMA) — a population the review itself flags. Where results disagree, it's largely about who was studied and absorption — which is the whole story of our next guide.

Why this is a daily practice, not a reactive one

Interfering with bacterial adhesion and supporting a healthy urinary environment both require the active compounds to be present consistently. A reservoir on the bladder wall doesn't respond to a single dose taken when you notice something — it responds to sustained, daily support. That's the shift from managing episodes to investing in the environment: tending the conditions, every day, before anything is wrong. It compounds.

How Semaine approaches this

Semaine's Urinary Tract Cleanse & Protect was built from this biology. It pairs Anthocran® Phytosome® — the specific, bioavailability-enhanced cranberry form used in the published research above — with standardized hibiscus, which supports the urinary environment's own defenses. Two ingredients, two angles: one reducing bacterial grip, the other supporting the environment they have to survive in. It's formulated as a daily product because that's what the biology calls for. It supports a healthy urinary environment and daily urinary tract health. Not a quick fix — a root fix.

Frequently asked questions

Why do my UTIs keep coming back even after antibiotics clear them?

Clearing the bacteria you can feel often leaves behind protected, biofilm-like reservoirs that uropathogenic E. coli form by invading the bladder's surface cells. That reservoir persists after symptoms fade and can reseed later — which reads as a new infection but is frequently the same population returning (Wu, Miao & Abraham, 2017).

How common are recurring UTIs?

The lifetime incidence of UTI in adult women is 50–60%, and prevalence roughly doubles after age 65 (Medina & Castillo-Pino, 2019). Recurrence after a first UTI is common (Fu et al., 2017).

Why did urinary issues start around menopause?

Declining estrogen changes the tissue and microbial balance of the urinary and vaginal environment, making it more hospitable to bacteria; the urinary microbiome itself shifts with menopause (Bhide et al., 2020).

Does cranberry actually work?

Yes, for the right people: the current landmark Cochrane review (2023) found cranberry cut symptomatic UTIs by 30% overall and 26% in women with recurrent UTIs (Williams et al., 2023). The active compounds (proanthocyanidins) reduce E. coli adhesion and inhibit biofilm formation in lab models, and where older studies disagreed it was largely absorption differences between cranberry products. See our evidence guide on why the form matters.

Why take a urinary supplement daily instead of only when symptoms start?

Because supporting the urinary environment and interfering with bacterial adhesion require the active compounds to be present consistently — it's preventive support, not a reactive treatment.

Educational content; not medical advice. If you have symptoms of an active infection, see a clinician. Sources are from peer-reviewed literature indexed on PubMed and linked above.

References

1. Anger J, Lee U, Ackerman AL, et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. J Urol. 2019. DOI: 10.1097/JU.0000000000000296 · PubMed
2. Baron G, Ferrario G, Marchetti M, et al. Profiling metabolites and behavioral effects in urine of humans after cranberry ingestion. Biochem Pharmacol. 2019. DOI: 10.1016/j.bcp.2019.113726 · PubMed
3. Bhide AA, Tailor V, Khullar V. Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome. Post Reprod Health. 2020. DOI: 10.1177/2053369120936426 · PubMed
4. de Llano DG, Esteban-Fernández A, Sánchez-Patán F, Martín-Álvarez PJ, Moreno-Arribas MV, Bartolomé B. Anti-Adhesive Activity of Cranberry Phenolic Compounds and Their Microbial-Derived Metabolites against Uropathogenic Escherichia coli in Bladder Epithelial Cell Cultures. Int J Mol Sci. 2015. DOI: 10.3390/ijms160612119 · PubMed
5. Eriksson I, Gustafson Y, Fagerström L, Olofsson B. Prevalence and factors associated with urinary tract infections (UTIs) in very old women. Arch Gerontol Geriatr. 2009. DOI: 10.1016/j.archger.2009.02.013 · PubMed
6. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010. DOI: 10.1038/nrurol.2010.190 · PubMed
7. Fu Z, Liska D, Talan D, Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr. 2017. DOI: 10.3945/jn.117.254961 · PubMed
8. Howell AB, Botto H, Combescure C, et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010. DOI: 10.1186/1471-2334-10-94 · PubMed
9. Juthani-Mehta M, Van Ness PH, Bianco L, et al. Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. JAMA. 2016. DOI: 10.1001/jama.2016.16141 · PubMed
10. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019. DOI: 10.1177/1756287219832172 · PubMed
11. Ottaviano JG, Sheng H, Chen J, et al. Cranberry Extract Inhibits Biofilm Formation by Candida albicans. Microorganisms. 2021. DOI: 10.3390/microorganisms9071492 · PubMed
12. Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018. DOI: 10.1038/s41585-018-0106-x · PubMed
13. Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023. DOI: 10.1002/14651858.CD001321.pub6 · PubMed
14. Wu J, Miao Y, Abraham SN. The multiple antibacterial activities of the bladder epithelium. Ann Transl Med. 2017. DOI: 10.21037/atm.2016.12.71 · PubMed